Molina Healthcare (NYSE:MOH) Price Target Cut to $339.00 by Analysts at Barclays

Molina Healthcare (NYSE:MOH) had its target price decreased by Barclays from $372.00 to $339.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight rating on the stock.

A number of other research analysts have also recently weighed in on MOH. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 31st. Robert W. Baird cut their target price on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. UBS Group dropped their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research note on Friday. Stephens restated an “equal weight” rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $355.67.

Molina Healthcare Trading Down 0.4 %

Shares of MOH opened at $283.92 on Friday. Molina Healthcare has a twelve month low of $272.69 and a twelve month high of $423.92. The company has a current ratio of 1.62, a quick ratio of 1.55 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $16.24 billion, a P/E ratio of 13.90, a PEG ratio of 0.94 and a beta of 0.54. The firm’s 50-day moving average is $298.55 and its two-hundred day moving average is $318.15.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, research analysts predict that Molina Healthcare will post 24.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Molina Healthcare

Hedge funds have recently modified their holdings of the stock. True Wealth Design LLC increased its position in Molina Healthcare by 2,500.0% during the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after buying an additional 74 shares during the period. Wingate Wealth Advisors Inc. purchased a new position in shares of Molina Healthcare in the 4th quarter worth $52,000. Financial Perspectives Inc acquired a new position in Molina Healthcare in the fourth quarter valued at $59,000. Finally, Lindbrook Capital LLC boosted its holdings in Molina Healthcare by 38.5% in the fourth quarter. Lindbrook Capital LLC now owns 205 shares of the company’s stock valued at $60,000 after acquiring an additional 57 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.